CCR5
Synonyms
CCR-5, Chemokine (C-C Motif) Receptor 5 (Gene/Pseudogene), C-C Motif Chemokine Receptor 5 A159A, Chemokine Recptor CCR5 Delta32, C-C Chemokine Receptor Type 5, Chemokine Receptor CCR5, CD195 Antigen, C-C CKR-5, CCCKR5, IDDM22, CKR-5, CKR5, Receptors, CCR5, C-C Motif Chemokine Receptor 5, CD195, CHEMR13, CCR5, HIV-1 fusion coreceptor, C-C Motif Chemokine Receptor 5 (Gene/Pseudogene), Chemokine (C-C Motif) Receptor 5, CC-CKR-5, CMKBR5,KO Status
F0
Drug Information
Launched drugs: 12
Drug in clinical trials: 1
Latest Research Phase:Approved
Drug Name
Code
Phase
Company
Indications
Clinical Trials
Maraviroc
MVC, UK-427857
Approved
Viiv Healthcare
HIV Infections, Acquired Immunodeficiency Syndrome, Arthritis, Rheumatoid
AGT 103-T
AGT 103-T
Preclinical
Applied Genetic Technologies Corporation
HIV Infections
Leronlimab
PA-14, PRO-140, HuPRO-140
NDA/BLA
Cytodyn
HIV Infections, Non-alcoholic Fatty Liver Disease, Coronavirus Disease 2019 (COVID-19), Graft vs Host Disease, Triple Negative Breast Neoplasms
PSC-RANTES
Preclinical
Mintaka Medical Research Foundation
HIV Infections
Cenicriviroc mesylate
CVC, TAK-652, TBR-652, CCR5/CCR2 antagonist
Phase 3 Clinical
Tobira Therapeutics, Takeda Pharmaceutical Co Ltd
Prediabetic State, HIV Infections, Acquired Immunodeficiency Syndrome, Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2, Liver Cirrhosis, Cholangitis, Sclerosing, Hepatic Insufficiency, Obesity, Cognition Disorders
Cenicriviroc mesylate/Tropifexor
LJC-242
Phase 2 Clinical
Novartis Pharma Ag
Non-alcoholic Fatty Liver Disease
CAL-1-transduced hematopoietic stem cell gene therapy (Calimmune)
Cal-1
Phase 2 Clinical
Calimmune
HIV Infections, Breast Neoplasms, Neoplasm Metastasis
Vicriviroc
SCH-D, MK-4176, SCH-417, Sch-417690
Phase 2 Clinical
Merck & Co Inc
HIV Infections, Acquired Immunodeficiency Syndrome, Colorectal Neoplasms
SB-728-T
SB-728-T, SB-728mR-T
Phase 2 Clinical
Sangamo Biosciences
HIV Infections
BMS-813160
BMS-813160
Phase 2 Clinical
Bristol-Myers Squibb Company
Pancreatic Neoplasms, Colorectal Neoplasms, Diabetic Nephropathies, Hyperplasia
SB-728-HSC
SB-728-HSC, SB-728-HSPC, SB-728mR-HSPC
Phase 1 Clinical
Sangamo Biosciences
HIV Infections
BMS-687681
BMS-687681
Phase 1 Clinical
Bristol-Myers Squibb Company
Neoplasms
Thioraviroc
Phase 1 Clinical
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences
HIV Infections
Emtricitabine/Maraviroc/Tenofovir Disoproxil Fumarate
Phase 1 Clinical
University Of Texas Medical Branch, Oak Crest Institute Of Science, National Institute Of Child Health And Human Development, Auritec Pharmaceuticals
HIV Infections
GSK-706769
GSK-706769
Phase 1 Clinical
Glaxosmithkline Plc
HIV Infections, Arthritis, Rheumatoid, Autoimmune Diseases
Vicriviroc/MK-2048
VCV/MK-2048, MK-2048A IVR, MK-2048/MK-4176, MK-4176/MK-2048
Pending
Merck Sharp & Dohme Corp, National Institute Of Allergy And Infectious Diseases
HIV Infections
Lamivudine/Maraviroc/Zidovudine
GSK-2838510
Pending
Glaxosmithkline Plc
HIV Infections
CCR5-targeting HIV vaccine (Kuros Biosciences)
CCR5Qb
Pending
Cytos
HIV Infections
VCH-286
VCH-286
Pending
Vertex Pharmaceuticals Incorporated
HIV Infections
INCB-009471
INCB-9471, INCB-009471
Pending
Incyte Corp
HIV Infections